Electric Field Therapy as an Alternative Medicine in the Clinical Management of Cancer

Michael D. Stine

International Journal of Sciences, 2015, vol. 4, issue 11, 7-9

Abstract: The company Novocure has developed a viable chemotherapy alternative in the form of electric field therapy. This Novocure product has been given FDA approval for recurrent glioblastoma. However, they currently have Phase I, Phase II and Phase III clinical trials underway for a variety of other cancers. The treatment is a noninvasive monotherapy and incorporates Tumor Treating Fields to interrupt mitotic division in rapidly dividing cells with a low number of adverse effects. Dr. Palti spearheaded this product and has outreached to over 2,200 patients, allowing them to receive treatment without major lifestyle modifications.

Date: 2015
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.ijsciences.com/pub/article/868 (text/html)
https://www.ijsciences.com/pub/pdf/V4201511868.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adm:journl:v:4:y:2015:i:11:p:7-9

Ordering information: This journal article can be ordered from
https://www.ijsciences.com/payment_guide.php

DOI: 10.18483/ijSci.868

Access Statistics for this article

More articles in International Journal of Sciences from Office ijSciences Alkhaer Publications Manchester M8 8XG England.
Bibliographic data for series maintained by Staff ijSciences ().